🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Xylem shares target raised on upbeat outlook

EditorNatashya Angelica
Published 06/06/2024, 03:00 am
XYL
-

On Wednesday, TD Cowen adjusted its outlook on Xylem (NYSE:XYL), a leading water technology company, by increasing its price target to $138 from $135 and maintaining a Buy rating on the stock. This revision comes after Xylem held an Investor Day event last week, which the firm indicated met the high expectations set for the company.

The Investor Day provided insights that support the current consensus estimates, which are trending towards earnings of nearly $5.00 per share for the fiscal year 2025. The firm acknowledged the challenges in surpassing these already attractive estimates. With the stock trading at nearly 30 times the earnings target, the firm suggests that near-term significant upside in the share price might be limited.

TD Cowen's new stock price target of $138 implies a valuation just under 29 times the projected fiscal year 2025 earnings per share and free cash flow. This change reflects the firm's confidence in Xylem's performance and the potential growth based on the current financial outlook.

Xylem's recent Investor Day highlighted the company's strategic initiatives and financial goals, providing investors with a clearer picture of the company's future. The event seems to have played a crucial role in reinforcing the firm's positive stance on the stock.

Investors and market watchers will likely monitor Xylem's progress towards achieving the outlined financial targets as the company continues to navigate the market. The updated price target serves as a signal of the firm's belief in Xylem's investment appeal based on the presented information and future earnings potential.

In other recent news, Xylem Inc (NYSE:XYL). has been in the spotlight with various financial firms adjusting their outlook on the company. Oppenheimer increased the price target for Xylem shares to $152, citing the company's strong growth framework and potential for sustained earnings growth. Similarly, Argus raised its price target to $165, highlighting the company's track record of market outperformance and dividend growth.

On the other hand, RBC Capital maintained an Outperform rating and a $162 price target for Xylem, emphasizing the company's strategy for growth and profitability. Notably, Xylem aims to improve margins by 100 basis points annually from 2024 to 2027, a significant increase from the previously anticipated 50-75 basis points.

Furthermore, Xylem's leadership team has outlined plans to achieve above-market growth and improve margins through business simplification efforts and integration of the recently acquired Evoqua.

The company's long-term financial framework projects annual organic revenue growth of 4% to 6%, with margin expansion expected to accelerate, resulting in mid-teens adjusted earnings per share growth annually. These are among the recent developments that have caught the attention of investors and analysts alike.

InvestingPro Insights

Adding to the insights from TD Cowen, InvestingPro data highlights Xylem's robust financial health and market performance. With a market capitalization of $33.77 billion and a noteworthy revenue growth of 39.51% over the last twelve months as of Q1 2024, Xylem showcases its capacity to expand in the competitive water technology sector. The company's commitment to shareholder returns is evident through its dividend, which has seen a growth of 9.09% in the same period, and it's worth noting that Xylem has raised its dividend for 14 consecutive years, a testament to its financial stability.

Analyzing the company's stock performance, Xylem has experienced a significant 30.31% price total return over the past six months, reflecting a strong market confidence that has also been echoed by 8 analysts who have revised their earnings upwards for the upcoming period. This bullish sentiment is further supported by the company's solid return on assets, which stands at 5.56%.

Investors seeking additional insights can explore more InvestingPro Tips, which include analyzing the company's moderate level of debt and its ability to operate with liquid assets that exceed short-term obligations. For those interested in a deeper dive into Xylem's investment potential, there are 14 additional tips available on InvestingPro. To enhance your investment strategy, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.